spacer
home > ebr > current issue
PUBLICATIONS

European Biopharmaceutical Review

ebr
Autumn 2021

   
Text
PDF
bullet
In Brief
The Secret Sauce

Practical and effective lipid nanoparticles are the critical enabling innovation making mRNA-based vaccines a practical reality. EBR Industry Advisor, Emile Bellott, looks at the background of this important advance in materials science and drug delivery
 
view
download pdf
bullet
Features
Down the Rabbit Hole: Navigating the Functional Genomics Funnel

Benjamin Borgo at Merck

The power to edit genomes at any scale has revolutionised drug discovery through the ability to create far truer representations of human biology than have ever been available
 
view
download pdf
The Route to Sustainable Procurement

George I’ons at Owen Mumford Pharmaceutical Services

How the biopharmaceutical industry is taking environmental responsibility head-on and forging a path towards a sustainable tomorrow
 
view
download pdf
bullet
Orphan Drug Development
 Overcoming Challenges in Orphan Drug Development

Rachel Smith at Veristat

While there is no ‘out-of-the-box’ roadmap for orphan drug development, through a toolkit of innovative solutions, we can address the unique aspects of clinical development in rare diseases, upfront
 
view
download pdf
Advancing Affordable Orphan Drug Development

Haishan Jang at BRIM Biotechnology

Haishan Jang, CEO at BRIM Biotechnology, reveals the biggest challenges of orphan drug development and the significant breakthroughs that are helping the pursuit of innovation
 
view
download pdf
Special Delivery

Sonya Montgomery at Evox Therapeutics

EBR sits down with Sonya Montgomery, Chief Medical Officer at Evox Therapeutics, to discuss how the power of exosomes can be harnessed to overcome the delivery issues in orphan drug development
 
view
download pdf
bullet
Antimicrobial Resistance
Diagnostics Leads the Fight Against Antimicrobial Resistance

François Lacoste at bioMérieux

While COVID-19 has been under a spotlight in the last year and a half, the threat of antimicrobial resistance remains critically urgent. Diagnostics could be pivotal in the development of effective solutions and to preserve antibiotic efficacy for future generations
 
view
download pdf
We Are Losing Our Strongest Allies Against Infectious Diseases

Alexander Sturm at Resistell

Antibiotic resistance and antibiotic tolerance are hindering our ability to slow the spread of infectious diseases, and the trends show that this may only be the start of the problem
 
view
download pdf
A Multifaceted Global Approach to Addressing Antimicrobial Resistance

Caroline Forkin at ICON

In a world threatened by AMR, prospects for improving diagnosis, treatment, and prevention could lie in global awareness and collaboration
 
view
download pdf
bullet
Biosimilars
Accelerating Biosimilars

Georg Feger at Fresenius Kabi

To ensure patients continue to experience the benefit of biosimilars, a solution to accelerate access will be vital in helping healthcare systems address some of their most critical challenges
 
view
download pdf
Elevate Your Biosimilars Through Branding

Nancy Globus, Manfred Weiler, Justin Holloway, Phil Ford, Andreas Reinbolz, and Jamie Cobb at Syneos Health

When it comes to biosimilars, saying that you are the same is not enough, and the sector is waking up to the realisation that simply offering a lower price is not the effortless road to riches it once may have seemed
 
view
download pdf
Structural Analytical Challenges in Biosimilar and Generic Drug Development

Richard Easton at BioPharmaSpec

The chemistry we perform on biologic molecules to tailor them for our own needs gives rise to challenges in structural analysis that will require technology, experience, and tools to structurally dissect these different classes of drugs
 
view
download pdf
bullet
Stem Cell Research and Technology
Regenerative Immunology: A New Era for the Treatment of Autoimmune Conditions

Giovanni Amabile at Enthera Pharmaceuticals

Inflammatory bowel disease and Type 1 diabetes are two autoimmune conditions that could benefit from a new regenerative medicine to rehabilitate specific pathways
 
view
download pdf
Probing Models of Neurological Disease in a Dish Using Multielectrode Arrays

James Ross at Axion BioSystems

Using induced pluripotent stem cells differentiated into neurons that recapitulate diseases, such as ALS and epilepsy, researchers are opening new doors for scientists to model and treat neurological diseases
 
view
download pdf
bullet
BIO-Europe 2021 Supplement
Welcome to the BIO-Europe® Digital 2021 Supplement in association with European Biopharmaceutical Review

Pam Putz at EBD Group
 
view
download pdf
Embracing Diagnostics to Hinder Antimicrobial Resistance

Chelsea Brooks at Sysmex Europe

Since the invention of groundbreaking antibiotics, such as penicillin, we have ignored the warning signs that lead to antimicrobial resistance, but it is hoped that new diagnostic tools can add to our growing armamentarium
 
view
download pdf
Innovative Technology Revolutionises Vaccine Development

BioCopy

With vaccine development under the microscope, BioCopy discusses its new molecular copier technology, which offers effective and, above all, fast protection against upcoming pandemics and rapidly changing virus strains
 
view
download pdf
Next-Generation Treatments to Cure Chronic Diseases

Evotec


 
view
download pdf
Pruning the Branches of Rare Cancer

Johanna Bendell at Roche

Oncology patients are faced with universal treatments that often fail to truly understand the complexity of each individual strain of cancer. Professors and doctors from around the world discuss the importance of orphan drugs to suit each disease and every person


 
view
download pdf
The Potential of Pluripotent Stem Cells for ‘Off-the-Shelf’ Cell Therapy

Alessandra De Riva and Eirini Koutsouraki at Mogrify

Human pluripotent stem cells are characterised by their undifferentiated status, infinite self-renewal capacity, and ability to differentiate into any cell type in the body. These characteristics make them an appealing source for therapeutic applications, from regenerative therapy to immuno-oncology
 
view
download pdf
Richter-Helm – The CDMO to Match Your Needs

Richter-Helm

One step ahead – biopharmaceutical production capacity enlargement
 
view
download pdf
   
spacer


Published quarterly in
January, April,
July, and October

News and Press Releases

Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables and Leachables testing services at its US Technology Excellence Center

Piombino Dese, Padua Italy and Salt Lake City, USA September 2, 2020: Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global provider of lab testing and expert advisory services signed today a partnership agreement that will provide Extractables and Leachables testing at SG US Technology Excellence Center in Boston, MA.
More info >>

White Papers

Inhaler Adherence: Exploring Key Factors

Aptar Pharma

Aptar Pharma recently hosted an expert panel roundtable on “Inhaler Adherence”. This international scientific forum was held in Paris, France on November 29th 2013. The roundtable was organized to explore and exchange views on the issues which may influence inhaler adherence/ compliance with a particular focus on asthma and C.O.P.D. therapies and their corresponding inhaler devices (MDIs, DPIs).
More info >>

Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement